Which footnotes in the MCG (Milliman Care Guidelines) criteria for pneumonia (M-282) provide additional information on managing antibiotic-resistant organisms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MCG Pneumonia (M-282) Footnotes for Antibiotic-Resistant Organisms

I cannot provide a definitive answer to this question because the provided evidence does not contain the actual MCG (Milliman Care Guidelines) document M-282 for pneumonia with its specific footnotes [E], [J], [K], or [D].

What the Evidence Does Contain

The evidence provided consists of:

  • Clinical practice guidelines from the American Thoracic Society, Infectious Diseases Society of America, and British Thoracic Society addressing community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP) 1

  • Praxis Medical Insights summaries of antibiotic regimens for CAP, including coverage for drug-resistant pathogens 2, 3

  • Research studies on antimicrobial resistance patterns, including drug-resistant Streptococcus pneumoniae (DRSP), methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, and multidrug-resistant organisms 4, 5, 6, 7, 8

Information on Antibiotic-Resistant Organisms in Pneumonia

While I cannot identify which MCG footnotes address resistant organisms, the evidence extensively covers this topic:

  • Drug-resistant Streptococcus pneumoniae (DRSP) is addressed with recommendations for high-dose amoxicillin, respiratory fluoroquinolones, or third-generation cephalosporins 1

  • MRSA coverage requires vancomycin or linezolid in patients with specific risk factors including prior MRSA infection, recent hospitalization with IV antibiotics, post-influenza pneumonia, or cavitary infiltrates 1, 2

  • Pseudomonas aeruginosa requires antipseudomonal β-lactams (piperacillin-tazobactam, cefepime, carbapenems) plus ciprofloxacin/levofloxacin or aminoglycosides in patients with structural lung disease, recent hospitalization, or prior P. aeruginosa isolation 1, 2

  • Multidrug-resistant gram-negative organisms including extended-spectrum β-lactamase (ESBL) producers are increasingly common in healthcare-associated pneumonia 5, 6, 8

Recommendation

To answer your specific question about MCG M-282 footnotes, you must access the actual MCG criteria document, as this proprietary guideline is not included in the evidence provided.

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

2
Guideline

Antibiotic Regimen Recommendations for Community-Acquired Pneumonia in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

3
Guideline

Cefepime Dosing for Ventilator-Associated Pneumonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4
Research

Appropriate use of antimicrobials for drug-resistant pneumonia: focus on the significance of beta-lactam-resistant Streptococcus pneumoniae.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002

Related Questions

What is the recommended antibiotic treatment for Streptococcus pneumoniae infections?
What is the next step in managing a patient with Mycoplasma pneumonia who remains febrile and has severe Acute Respiratory Distress Syndrome (ARDS) despite treatment with macrolide (e.g. azithromycin) antibiotics?
What antibiotic treatment is recommended for a patient with pneumonia caused by Streptococcus pneumoniae with a susceptible dose-dependent Minimum Inhibitory Concentration (MIC)?
What are the recommended antibiotic regimens for community-acquired pneumonia?
What is the most appropriate antibiotic for a patient with pneumonia, penicillin allergy, and alpha-hemolytic Streptococcus, currently on aztreonam?
What is the appropriate dosage and administration of L-ornithine L-aspartate (L-ornithine L-aspartate) for an adult patient with potential impaired renal function and a possible diagnosis of hepatic encephalopathy?
Can an elderly female with a regular workout routine benefit from taking creatine (a dietary supplement) daily to improve muscle strength and endurance?
What is the best Selective Serotonin Reuptake Inhibitor (SSRI) for a patient with hyponatremia and sexual dysfunction?
How do you differentiate and manage Transfusion-Associated Circulatory Overload (TACO) versus Transfusion-Related Acute Lung Injury (TRALI) in a patient with a history of heart disease who develops respiratory distress after a blood transfusion?
What is the recommended approach for patients with out-of-hospital cardiac arrest (OHCA), specifically regarding early invasive strategy including cardiac catheterization, and what are the implications of the Tomahawk and MIRACLE trials?
Is Bactrim (trimethoprim/sulfamethoxazole) a suitable treatment option for an adult patient with an uncomplicated urinary tract infection (UTI) and no known allergy to sulfa medications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question